Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy Review Abstract Purpose: This paper examines current approaches to lipid management in family practice, focusing on risk stratification methods, the role of coronary artery calcium scoring, and implementation of
Author: Similoluwa Oluwalana
Intravenous Lipid Rescue: Why It’s Saving Lives Far Beyond Local Anesthetic Toxicity
Intravenous Lipid Rescue: Why It’s Saving Lives Far Beyond Local Anesthetic Toxicity Review Abstract Intravenous lipid emulsion therapy, originally developed as nutritional support, has emerged as a critical rescue intervention for drug toxicity cases well beyond its initial application in local anesthetic systemic toxicity. This
The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden
The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden Review Abstract Lipidology is undergoing a clinically important transition from traditional cholesterol-centered assessment toward a more precise evaluation of atherogenic lipoprotein burden. Low-density lipoprotein cholesterol (LDL-C) remains a validated therapeutic target
What a Closed Loop System for Insulin Delivery Contains: Breaking Down Artificial Pancreas Technology in 2026
What a Closed Loop System for Insulin Delivery Contains: Breaking Down Artificial Pancreas Technology in 2026 Review Key Takeaways Closed-loop insulin delivery systems represent a revolutionary advancement in diabetes management, combining three essential components to automate blood sugar control and significantly improve patient outcomes.
UTI Care: When to Treat Symptoms, When to Culture, Recurrent UTI Pathways
UTI Care: When to Treat Symptoms, When to Culture, Recurrent UTI Pathways Review Abstract Urinary tract infections (UTIs) are among the most common bacterial infections encountered in clinical practice, affecting millions of patients annually. This paper examines evidence-based approaches to UTI management, focusing on three
The Role of Anesthesiologists in Perioperative Medicine: Should We Lead or Follow?
The Role of Anesthesiologists in Perioperative Medicine: Should We Lead or Follow? Review Abstract Anesthesiologists have evolved from providers of intraoperative anesthesia to physicians involved in the complete perioperative care continuum. This paper examines the current role of anesthesiologists in perioperative medicine and addresses whether
Pediatric Immunology Breakthroughs: Can Tolerogenic Therapies Cure Autoimmune Disease?
Pediatric Immunology Breakthroughs: Can Tolerogenic Therapies Cure Autoimmune Disease? Review Key Takeaways Revolutionary tolerogenic therapies are transforming pediatric autoimmune disease treatment from chronic management to potential cures, offering hope for children with severe conditions. CAR T-cell therapy achieves remarkable results: 7 of 8 pediatric
The Vitamin D Debate: From Universal Supplement to Precision Therapy
The Vitamin D Debate: From Universal Supplement to Precision Therapy Review Abstract Vitamin D supplementation has evolved from a simple solution to rickets into one of medicine’s most debated therapeutic interventions. This paper examines the current evidence surrounding vitamin D’s role in health and disease,
The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback?
The Return of Old Antibiotics: Are Colistin and Fosfomycin Making a Comeback? Review Abstract The rise of multidrug-resistant bacterial infections has forced clinicians to reconsider older antimicrobial agents previously abandoned due to toxicity concerns. Colistin and fosfomycin, antibiotics discovered decades ago, have experienced renewed clinical
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine?
The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine? Review Abstract The rapid expansion of biomarker discovery and clinical application has created both unprecedented opportunities and substantial challenges in modern medicine. This analysis examines whether the current biomarker boom represents genuine progress
